Effect of false-positive results on reattendance at breast cancer screening programmes in Spain

European Journal of Public Health

Volumn 22, Issue 3, 2012, Pages 404-408

  Álamo Junquera, Dolores ^a,b   Murta Nascimento, Cristiane ^a   MacI, Francesc ^a,c   Baré, Marisa ^d   Galcerán, Jaume ^e   Ascunce, Nieves ^f   Zubizarreta, Raquel ^g   Salas, Dolores ^h   Román, Rubén ^a,c   Castells, Xavier ^a,c   Sala, Maria ^a,c  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Institut Universitari Parc Tauli UAB   (Spain)

^e Programa de Detecció Preco Del Cncer de Mama de Tarragona Terres de l'Ebre   (Spain)

^f INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^g Xunta de Galicia   (Spain)

^h Dirección General de Salud Pública   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; EARLY DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAMMOGRAPHY; METHODOLOGY; MIDDLE AGED; PATIENT ATTITUDE; RADIOGRAPHY; SPAIN; STATISTICS;

ADULT; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SPAIN;

EID: 84861613205     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckr057     Document Type: Article

References (32)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr (10 October 2010, date last accessed).
2. Pollan M, Pastor-Barriuso R, Ardanaz E, et al. Recent changes in breast cancer incidence in Spain, 1980-2004. J Natl Cancer Inst 2009;101:1584-91.
3. Fletcher SW, Black W, Harris R, et al. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993;85:1644-56.
4. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
5. Nystrom L, Andersson I, Bjurstam N, et al. Longterm effects of mammography screening updated overview of the Swedish randomized trials. Lancet 2002;359:909-19.
6. Deck W, Kakuma R. Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS). Screening mammography: a reassessment. Montreal, Quebec: AETMIS, 2006. Available at: http://www.aetmis.gouv.qc.ca/site/ download.php?f=f246e174f2110930d 0b6291324df36b5 (10 October 2010, date last accessed).
7. Castells X, Molins E, Macià F. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme. J Epidemiol Community Health 2006;60:316-21.
8. Salz T, Richman AR, Brewer NT. Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes. Psychooncology 2010;19:1026-34.
9. Johnson MM, Hislop TG, Kan L, et al. Compliance with the screening mammography program of British Columbia: will she return? Can J Public Health 1996;87:176-80.
10. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res 2002;4:R11.
11. Chiarelli AM, Moravan V, Halapy E, et al. False-positive result and reattendance in the Ontario Breast Screening Program. J Med Screen 2003;10:129-33.
12. Hofvind SS, Wang H, Thoresen S. The Norwegian Breast Cancer Screening Program: re-attendance related to the women's experiences, intentions and previous screening result. Cancer Causes Control 2003;14:391-8.
13. Seigneurin A, Exbrayat C, Labarère J, et al. Association of diagnostic work-up with subsequent attendance in a breast cancer screening program for false-positive cases. Breast Cancer Res Treat 2011;127:221-8.
14. Andersen SB, Vejborg I, von Euler-Chelpin M. Participation behaviour following a false positive test in the Copenhagen mammography screening programme. Acta Oncol 2008;47:550-5.
15. Pisano ED, Earp J, Schell M, et al. Screening behavior of women after a false-positive mammogram. Radiology 1998;208:245-9.
16. O'Sullivan I, Sutton S, Dixon S, Perry N. False positive results do not have a negative effect on reattendance for subsequent breast screening. J Med Screen 2001;8:145-8.
17. Lampic C, Thurfjell E, Sjoden PO. The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer. Eur J Cancer 2003;39:1730-7.
18. Burman ML, Taplin SH, Herta DF, et al. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med 1999;131:1-6.
19. Lipkus IM, Halabi S, Strigo TS, Rimer BK. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psychooncology 2000;9:402-10.
20. Pinckney RG, Geller BM, Burman M, Littenberg B. Effect of false-positive mammograms on return for subsequent screening mammography. Am J Med 2003;114:120-5.
21. Roman R, Sala M, Salas D, et al. Cumulative false positive risk for all procedures and for invasive procedures in breast cancer screening programs according to the reading protocol and women's characteristics. Ann Oncol 2011. (in press).
22. Perry N, Broeders M, de Wolf C, et al, editors. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis, 4th edn. Luxembourg: Office for Official Publications of the European Communities, 2006, Available at http://screening.iarc.fr/doc/ ND7306954ENC-002.pdf (10 October 2010, date last accessed).
23. Ascunce N, Ederra M, Barcos A, et al.Situacion del cribado de cancer de mama en España: caracter?sticas y principales resultados de los programas existentes. In: Castells X (coord.). Descripcion del cribado del cancer en España. Proyecto DESCRIC. Madrid: Plan de Calidad para el Sistema Nacional de Salud. Ministerio de Sanidad y Consumo. Barcelona: Agència d'Avaluacio de Tecnologia i Recerca Mèdiques de Cataluña, 2007. Available at: http://www .gencat.cat/salut/depsan/units/aatrm/pdf/in0601es.pdf (10 February 2011, date last accessed).
24. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med 2001;23:292-300.
25. Marteau TM. Psychology and screening: narrowing the gap between efficacy and effectiveness. Br J Clin Psychol 1994;33:1-10.
26. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502-10.
27. Bulliard JL, De Landtsheer JP, Levi F. Reattendance in the Swiss mammography screening pilot programme. J Med Screen 2004;11:59-64.
28. Agencia de Salut Pu blica de Barcelona. (ASP). Enquesta de Salut de Barcelona. 2006. Barcelona, España; 2006. Available at: http://www.aspb.es/quefem/docs/ EnquestaSalutBCN%202006%20Resultat%20detallats. pdf (10 October 2010, date last accessed).
29. Van Landeghem P, Bleyen L, Villeirs G, De Backer G. Re-attendance in the Flemish mammography breast cancer screening programme, Belgium. Results from the Centre for prevention and Early Detection of Cancer, Ghent University. Arch Public Health 2006;64:81-92.
30. Liston J, Wilson R, editors. Quality Assurance Guidelines For Breast Cancer Screening Radiology. NHSBSP Publication No 59. 2005. Available at: http://www.cancerscreening. nhs.uk/breastscreen/publications/nhsbsp59.pdf (10 February 2011, date last accessed).
31. Bare ML, Montes J, Florensa R, et al. Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 2003;12:487-94.
32. Esteva M, Ripoll J, Leiva A, et al. Determinants of non attendance to mammography program in a region with high voluntary health insurance coverage. BMC Public Health 2008;8:387.